(PDF) Late Recurrence of Retinopathy of Prematurity After

Late Recurrence of Retinopathy of Prematurity After Treatment With Both Intravitreal Bevacizumab and Laser

Journal of AAPOS - United States

doi 10.1016/j.jaapos.2014.03.011

Full Text

Abstract

Available in full text

Categories

Date

August 1, 2014

Authors

Agnieshka Baumritter

Denise J. Pearson

Albert M. Maguire

Graham E. Quinn

Publisher

Elsevier BV

Related search

Comparison of Intravitreal Ranibizumab and Bevacizumab Treatment for Retinopathy of Prematurity

Arquivos Brasileiros de Oftalmologia

English

Intravitreal Bevacizumab for Retinopathy of Prematurity in Infants Ineligible for Laser Therapy*

Turkish Journal of Medical Sciences

English

Recurrence of Retinopathy of Prematurity After Intravitreal Ranibizumab Monotherapy: Timing and Risk Factors

Investigative Ophthalmology and Visual Science

Molecular Neuroscience

Sensory Systems

English

A Lower Dose of Intravitreal Bevacizumab Effectively Treats Retinopathy of Prematurity

Journal of AAPOS

English

Neurodevelopmental Outcomes After Extreme Prematurity Comparing Bevacizumab to Laser Surgery for Type 1 Retinopathy of Prematurity

Developmental Medicine and Child Neurology

Developmental Neuroscience

English

Intravitreal Bevacizumab as Single Drug Therapy for Retinopathy of Prematurity in 12 Patients

Archivos Argentinos de Pediatria

English

Diode Laser Treatment of Posterior Retinopathy of Prematurity

British Journal of Ophthalmology

Molecular Neuroscience

Sensory Systems

English

Low Dose Versus Conventional Dose of Intravitreal Bevacizumab Injection for Retinopathy of Prematurity: A Case Series With Paired-Eye Comparison

Acta Ophthalmologica

English

Different Refractive Errors in Triplets With Retinopathy of Prematurity Treated With Bevacizumab

Journal of Pediatric Ophthalmology and Strabismus

English